Genetic Analysis: Development project initiated for a new companion diagnostic test
OSLO, NORWAY – 12 October 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that the Company has successfully completed a pilot project and initiated a development project in collaboration with a global pharmaceutical company to develop a new microbiome-based rapid companion* diagnostic PCR test. The development project’s goal is to provide clinicians with a decision tool for prescribing treatment and monitoring treatment effects aimed at faster clinical decision-making.A new microbiome diagnostic test providing rapid testing in human microbiomes is the goal